Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,091 | 1,257 | 98.8% |
| Education | $251.66 | 8 | 1.0% |
| Gift | $34.46 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $6,987 | 327 | $0 (2024) |
| Janssen Biotech, Inc. | $4,383 | 273 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,082 | 134 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,304 | 70 | $0 (2024) |
| Gilead Sciences, Inc. | $1,265 | 45 | $0 (2024) |
| Celgene Corporation | $1,123 | 71 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $657.72 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $566.78 | 35 | $0 (2022) |
| GENZYME CORPORATION | $438.88 | 7 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $437.35 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,338 | 135 | ABBVIE INC. ($919.67) |
| 2023 | $4,045 | 175 | AbbVie Inc. ($1,130) |
| 2022 | $3,703 | 192 | ABBVIE INC. ($1,347) |
| 2021 | $2,842 | 145 | Janssen Biotech, Inc. ($760.37) |
| 2020 | $1,461 | 79 | AbbVie Inc. ($478.70) |
| 2019 | $3,014 | 166 | AbbVie, Inc. ($922.72) |
| 2018 | $3,480 | 211 | AbbVie, Inc. ($843.71) |
| 2017 | $2,495 | 163 | AbbVie, Inc. ($683.54) |
All Payment Transactions
1,266 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.02 | General |
| Category: GI | ||||||
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $40.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Immunology | ||||||
| 11/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: Immunology | ||||||
| 11/01/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/28/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | — | Food and Beverage | In-kind items and services | $107.10 | General |
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $31.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,334 | 1,668 | $567,060 | $158,130 |
| 2022 | 14 | 1,156 | 1,352 | $469,570 | $144,501 |
| 2021 | 14 | 1,307 | 1,505 | $580,130 | $165,331 |
| 2020 | 15 | 1,178 | 1,347 | $441,015 | $136,611 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 174 | 174 | $130,500 | $32,747 | 25.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 147 | 154 | $42,350 | $21,435 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 229 | $40,075 | $21,218 | 52.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 153 | 300 | $29,730 | $18,869 | 63.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 158 | 166 | $103,900 | $11,892 | 11.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 96 | 97 | $72,750 | $11,124 | 15.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 41 | 42 | $35,700 | $7,323 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 93 | $11,160 | $6,193 | 55.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $8,775 | $4,601 | 52.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 74 | 160 | $28,800 | $4,369 | 15.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $7,600 | $3,472 | 45.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 26 | 59 | $10,620 | $3,268 | 30.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 16 | 16 | $11,200 | $3,038 | 27.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 26 | 31 | $5,580 | $2,118 | 38.0% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 19 | 19 | $13,300 | $2,093 | 15.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $3,800 | $2,018 | 53.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 13 | $7,800 | $1,902 | 24.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 12 | 19 | $3,420 | $450.41 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 242 | $42,350 | $23,438 | 55.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 135 | 142 | $39,050 | $22,936 | 58.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 99 | 99 | $74,250 | $19,250 | 25.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 161 | 298 | $26,820 | $17,473 | 65.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 114 | 114 | $85,500 | $14,670 | 17.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 142 | 150 | $82,500 | $10,941 | 13.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 49 | 49 | $41,650 | $7,575 | 18.2% |
About Dr. Mark Devore, MD
Dr. Mark Devore, MD is a Gastroenterology healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578521217.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Devore, MD has received a total of $24,377 in payments from pharmaceutical and medical device companies, with $3,338 received in 2024. These payments were reported across 1,266 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($24,091).
As a Medicare-enrolled provider, Devore has provided services to 4,975 Medicare beneficiaries, totaling 5,872 services with total Medicare billing of $604,573. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Southfield, MI
- Active Since 05/03/2006
- Last Updated 05/11/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1578521217
Products in Payments
- STELARA (Biological) $4,431
- ZEPOSIA (Drug) $1,480
- RINVOQ (Biological) $1,383
- Humira (Biological) $1,204
- XIFAXAN (Drug) $1,149
- SKYRIZI (Biological) $935.63
- ENTYVIO (Biological) $890.42
- HUMIRA (Biological) $786.67
- DUPIXENT (Biological) $752.36
- Entyvio (Biological) $708.19
- Mavyret (Drug) $690.15
- Epclusa (Drug) $679.17
- MAVYRET (Drug) $635.62
- ZENPEP (Drug) $516.76
- LINZESS (Drug) $466.44
- OCALIVA (Drug) $433.18
- REMICADE (Biological) $315.54
- Trulance (Drug) $300.15
- TREMFYA (Drug) $294.42
- MOVIPREP (Drug) $290.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Southfield
Reena Patel, M.d, M.D
Gastroenterology — Payments: $15,063
Dr. Sami Akkary, M.d, M.D
Gastroenterology — Payments: $6,344
Dr. David Benkoff, M.d, M.D
Gastroenterology — Payments: $2,365
Dr. Pooja Mude, Do, DO
Gastroenterology — Payments: $2,289
Fares Hakim, Md, MD
Gastroenterology — Payments: $1,915
Katia El Jurdi
Gastroenterology — Payments: $1,582